# Basal Tumours in Bladder Cancer, Response to chemoTherapy

> **NCT04089748** · — · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 293 (actual)

## Conditions studied

- Bladder Cancer
- Chemotherapy Effect

## Interventions

- **COMBINATION_PRODUCT:** neoadjuvant chemotherapy with cisplatine

## Key facts

- **NCT ID:** NCT04089748
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-27
- **Primary completion:** 2019-04-29
- **Final completion:** 2019-04-29
- **Target enrollment:** 293 (ACTUAL)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04089748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04089748, "Basal Tumours in Bladder Cancer, Response to chemoTherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04089748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*